T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Fulcrum Therapeutics
FULC
$392M
| $108K | ﹤0.01% |
15,900
| – | – |
|
2702
Omeros
OMER
$290M
| $108K | ﹤0.01% |
32,933
+1,705
| +5% | +$5.59K |
|
|
SUP
2703
DELISTED
Superior Industries International
SUP
| $108K | ﹤0.01% |
33,700
| – | – |
|
2704
Ocugen
OCGN
$322M
| $108K | ﹤0.01% |
187,100
+93,000
| +99% | +$53.7K |
|
2705
iQIYI
IQ
$2.69B
| $107K | ﹤0.01% |
21,820
+9,120
| +72% | +$44.7K |
|
2706
Esperion Therapeutics
ESPR
$512M
| $106K | ﹤0.01% |
35,400
| – | – |
|
2707
Mammoth Energy Services
TUSK
$112M
| $105K | ﹤0.01% |
23,326
+574
| +3% | +$2.58K |
|
2708
Cantaloupe
CTLP
$792M
| $104K | ﹤0.01% |
13,912
+828
| +6% | +$6.19K |
|
2709
Stereotaxis
STXS
$263M
| $103K | ﹤0.01% |
58,400
| – | – |
|
|
VIA
2710
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $103K | ﹤0.01% |
10,880
| – | – |
|
2711
Lineage Cell Therapeutics
LCTX
$290M
| $100K | ﹤0.01% |
90,896
+5,560
| +7% | +$6.12K |
|
2712
FibroGen
FGEN
$46.4M
| $99K | ﹤0.01% |
4,456
+1,628
| +58% | +$36.2K |
|
2713
MaxCyte
MXCT
$151M
| $99K | ﹤0.01% |
20,879
+2,082
| +11% | +$9.87K |
|
2714
Telos
TLS
$464M
| $99K | ﹤0.01% |
27,006
| – | – |
|
2715
Bit Digital
BTBT
$890M
| $97K | ﹤0.01% |
22,888
+7,419
| +48% | +$31.4K |
|
2716
GoodRx Holdings
GDRX
$1.43B
| $96K | ﹤0.01% |
14,300
| – | – |
|
2717
NextDecade
NEXT
$2.6B
| $96K | ﹤0.01% |
+20,053
| New | +$96K |
|
2718
Citizens
CIA
$263M
| $94K | ﹤0.01% |
34,900
| – | – |
|
2719
Clarus
CLAR
$154M
| $94K | ﹤0.01% |
13,505
+917
| +7% | +$6.38K |
|
2720
Kartoon Studios
TOON
$38.6M
| $93K | ﹤0.01% |
66,240
| – | – |
|
2721
TeraWulf
WULF
$4.04B
| $93K | ﹤0.01% |
38,632
+9,090
| +31% | +$21.9K |
|
2722
Farmer Brothers
FARM
$43.1M
| $91K | ﹤0.01% |
29,600
| – | – |
|
2723
FTAI Infrastructure
FIP
$460M
| $91K | ﹤0.01% |
23,239
+1,519
| +7% | +$5.95K |
|
2724
GCM Grosvenor
GCMG
$678M
| $91K | ﹤0.01% |
+10,120
| New | +$91K |
|
2725
Forge Global Holdings
FRGE
$243M
| $90K | ﹤0.01% |
1,735
+114
| +7% | +$5.91K |
|